Terms: = Colorectal cancer AND GATA2, NFE1B, 2624, ENSG00000179348, MGC2306, P23769 AND Diagnosis
2 results:
1. The metabolic syndrome and its components as prognostic factors in colorectal cancer: A meta-analysis and systematic review.
Lu B; Qian JM; Li JN
J Gastroenterol Hepatol; 2023 Feb; 38(2):187-196. PubMed ID: 36287138
[TBL] [Abstract] [Full Text] [Related]
2. Identification of Prognostic Biomarker Signatures and Candidate Drugs in colorectal cancer: Insights from Systems Biology Analysis.
Rahman MR; Islam T; Gov E; Turanli B; Gulfidan G; Shahjaman M; Banu NA; Mollah MNH; Arga KY; Moni MA
Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658502
[TBL] [Abstract] [Full Text] [Related]
